P. O'Connor, D. Jankovic, M. Muscat, M. Ben-Mamou, S. Reef, M

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Vaccines for the elderly

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase S. Santibanez, J.M. Hübschen, M.C.

P. Gautret, E. Botelho-Nevers, P. Brouqui, P. Parola

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

Migration and infectious diseases

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus T. Bärnighausen, D.E. Bloom, E.T. Cafiero,

E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Refugee crisis and re-emergence of forgotten infections in Europe

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

J. M. Hübschen, S. M. Bork, K. E. Brown, A. Mankertz, S. Santibanez, M

Public health significance of invasive mosquitoes in Europe

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Louis Pasteur, from crystals of life to vaccination

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Vector control: a cornerstone in the malaria elimination campaign

P.L. Lopalco, P. Carrillo Santisteve

Training for the infectious diseases speciality in Norway

Leucocyte esterase, glucose and C-reactive protein in the diagnosis of prosthetic joint infections: a prospective study E. De Vecchi, F. Villa, M. Bortolin,

P. Carrillo-Santisteve, P.L. Lopalco

Laboratory diagnosis and biosafety issues of biological warfare agents

E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Can we control all-cause meningococcal disease in Europe?

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Community-acquired pneumonia: epidemiologic and clinical consideration

The role of antimalarial treatment in the elimination of malaria

Abstracts cont. Clinical Microbiology and Infection

Vaccinations against respiratory tract infections at Hajj

Vaccines for the elderly

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

Influence of climate change on the incidence and impact of arenavirus diseases: a speculative assessment J.C. Clegg Clinical Microbiology and Infection

Are we losing the fight against malaria one more time?

The state of measles and rubella in the WHO European Region, 2013

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Great oaks from little acorns grow—21 years of CMI

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Measles and rubella elimination in the WHO Region for Europe: progress and challenges P. O'Connor, D. Jankovic, M. Muscat, M. Ben-Mamou, S. Reef, M. Papania, S. Singh, T. Kaloumenos, R. Butler, S. Datta Clinical Microbiology and Infection Volume 23, Issue 8, Pages 504-510 (August 2017) DOI: 10.1016/j.cmi.2017.01.003 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Map compares measles incidence rates in 2012 and 2015 in the WHO European Region. Clinical Microbiology and Infection 2017 23, 504-510DOI: (10.1016/j.cmi.2017.01.003) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Graph shows measles and rubella cases, and first and second doses of measles-containing vaccine (MCV1 and MCV2) coverage by year (1980–2015) in the WHO European Region. Data source: WHO/UNICEF Joint Reporting Form data; 1980–2015 (data as of 1 November 2016). Clinical Microbiology and Infection 2017 23, 504-510DOI: (10.1016/j.cmi.2017.01.003) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 3 Map shows first and second doses of measles-containing vaccine (MCV1 and MCV2) coverage in 2015 in the WHO European Region. Clinical Microbiology and Infection 2017 23, 504-510DOI: (10.1016/j.cmi.2017.01.003) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 4 Graph shows the characteristics of age groups affected by measles by year (2006–2015) in the WHO European Region. Data source: WHO/UNICEF Joint Reporting Form data; 2006–2015 (data as of 1 November 2016). Clinical Microbiology and Infection 2017 23, 504-510DOI: (10.1016/j.cmi.2017.01.003) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions